KEGG   PATHWAY: dnm04650
Entry
dnm04650                    Pathway                                
Name
Natural killer cell mediated cytotoxicity - Dasypus novemcinctus (nine-banded armadillo)
Description
Natural killer (NK) cells are lymphocytes of the innate immune system that are involved in early defenses against both allogeneic (nonself) cells and autologous cells undergoing various forms of stress, such as infection with viruses, bacteria, or parasites or malignant transformation. Although NK cells do not express classical antigen receptors of the immunoglobulin gene family, such as the antibodies produced by B cells or the T cell receptor expressed by T cells, they are equipped with various receptors whose engagement allows them to discriminate between target and nontarget cells. Activating receptors bind ligands on the target cell surface and trigger NK cell activation and target cell lysis. However Inhibitory receptors recognize MHC class I molecules (HLA) and inhibit killing by NK cells by overruling the actions of the activating receptors. This inhibitory signal is lost when the target cells do not express MHC class I and perhaps also in cells infected with virus, which might inhibit MHC class I exprssion or alter its conformation. The mechanism of NK cell killing is the same as that used by the cytotoxic T cells generated in an adaptive immune response; cytotoxic granules are released onto the surface of the bound target cell, and the effector proteins they contain penetrate the cell membrane and induce programmed cell death.
Class
Organismal Systems; Immune system
Pathway map
dnm04650  Natural killer cell mediated cytotoxicity
dnm04650

Other DBs
GO: 0042267
Organism
Dasypus novemcinctus (nine-banded armadillo) [GN:dnm]
Gene
101410923  IFNB1; interferon beta [KO:K05415]
101411103  PRF1; perforin-1 [KO:K07818]
101411498  PLCG1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 [KO:K01116] [EC:3.1.4.11]
101411550  [KO:K07818]
101411989  BRAF; LOW QUALITY PROTEIN: serine/threonine-protein kinase B-raf [KO:K04365] [EC:2.7.11.1]
101412233  KRAS; GTPase KRas isoform X4 [KO:K07827]
101413140  [KO:K06541]
101413233  FAS; tumor necrosis factor receptor superfamily member 6 isoform X1 [KO:K04390]
101413806  [KO:K06463]
101414043  RAC3; ras-related C3 botulinum toxin substrate 3 [KO:K07861]
101414233  FYN; tyrosine-protein kinase Fyn isoform X1 [KO:K05703] [EC:2.7.10.2]
101414240  [KO:K07828]
101414445  [KO:K06516]
101414681  [KO:K06742]
101416459  VAV1; proto-oncogene vav isoform X1 [KO:K05730]
101416634  IFNGR1; interferon gamma receptor 1 [KO:K05132]
101417008  NFATC2; nuclear factor of activated T-cells, cytoplasmic 2 isoform X1 [KO:K17332]
101417353  FASLG; tumor necrosis factor ligand superfamily member 6 [KO:K04389]
101417480  SHC3; LOW QUALITY PROTEIN: SHC-transforming protein 3 [KO:K17448]
101417876  LAT; linker for activation of T-cells family member 1 [KO:K07362]
101418868  [KO:K05414]
101419167  ARAF; serine/threonine-protein kinase A-Raf [KO:K08845] [EC:2.7.11.1]
101419317  [KO:K05414]
101419480  HRAS; GTPase HRas isoform X1 [KO:K02833]
101419645  [KO:K01353] [EC:3.4.21.79]
101419758  [KO:K05414]
101420075  PPP3CC; LOW QUALITY PROTEIN: serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform [KO:K04348] [EC:3.1.3.16]
101420445  TNF; tumor necrosis factor [KO:K03156]
101420546  [KO:K04369] [EC:2.7.12.2]
101421021  [KO:K06516]
101421086  RAC1; LOW QUALITY PROTEIN: ras-related C3 botulinum toxin substrate 1 [KO:K04392]
101421211  RAF1; RAF proto-oncogene serine/threonine-protein kinase isoform X1 [KO:K04366] [EC:2.7.11.1]
101421425  TYROBP; TYRO protein tyrosine kinase-binding protein isoform X1 [KO:K07992]
101421680  PRKCB; protein kinase C beta type isoform X1 [KO:K19662] [EC:2.7.11.13]
101422156  GRB2; growth factor receptor-bound protein 2 [KO:K04364]
101422351  [KO:K06516]
101422617  SHC4; SHC-transforming protein 4 [KO:K17449]
101422721  [KO:K01353] [EC:3.4.21.79]
101422758  HCST; hematopoietic cell signal transducer isoform X1 [KO:K07988]
101422877  IFNG; interferon gamma [KO:K04687]
101423099  [KO:K07360] [EC:2.7.10.2]
101423469  [KO:K06856]
101423744  [KO:K02649]
101423951  [KO:K06728]
101424698  [KO:K06541]
101424799  CSF2; granulocyte-macrophage colony-stimulating factor [KO:K05427]
101425111  [KO:K05414]
101425248  CD247; T-cell surface glycoprotein CD3 zeta chain isoform X1 [KO:K06453]
101425494  IFNGR2; interferon gamma receptor 2 [KO:K05133]
101425586  [KO:K06541]
101425952  IFNAR1; interferon alpha/beta receptor 1 [KO:K05130]
101426115  [KO:K01353] [EC:3.4.21.79]
101426836  IFNAR2; interferon alpha/beta receptor 2 isoform X1 [KO:K05131]
101426945  PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [KO:K00922] [EC:2.7.1.153]
101427070  [KO:K06541]
101427372  ICAM1; intercellular adhesion molecule 1 [KO:K06490]
101427629  PPP3CA; serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform isoform X1 [KO:K04348] [EC:3.1.3.16]
101427882  NFATC1; LOW QUALITY PROTEIN: nuclear factor of activated T-cells, cytoplasmic 1 [KO:K04446]
101428380  [KO:K06516]
101428386  PLCG2; LOW QUALITY PROTEIN: 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 [KO:K05859] [EC:3.1.4.11]
101428773  SH3BP2; SH3 domain-binding protein 2 [KO:K07984]
101429122  [KO:K06541]
101429344  LCP2; lymphocyte cytosolic protein 2 isoform X2 [KO:K07361]
101429504  ITGAL; integrin alpha-L [KO:K05718]
101429553  [KO:K06541]
101429660  VAV3; guanine nucleotide exchange factor VAV3 [KO:K05730]
101430275  CD244; natural killer cell receptor 2B4 isoform X1 [KO:K06582]
101430570  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
101430817  NRAS; GTPase NRas [KO:K07828]
101431291  CD48; CD48 antigen [KO:K06479]
101431573  [KO:K06516]
101431999  [KO:K06541]
101432987  [KO:K05414]
101433347  PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649]
101433438  LAT2; linker for activation of T-cells family member 2 isoform X1 [KO:K26356]
101433544  SOS2; son of sevenless homolog 2 [KO:K03099]
101433621  SH2D1A; SH2 domain-containing protein 1A isoform X1 [KO:K07990]
101434090  [KO:K06541]
101434965  ICAM2; intercellular adhesion molecule 2 [KO:K06523]
101435063  PTPN11; tyrosine-protein phosphatase non-receptor type 11 isoform X2 [KO:K07293] [EC:3.1.3.48]
101435268  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 isoform X1 [KO:K04368] [EC:2.7.12.2]
101435351  PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649]
101435353  PTPN6; tyrosine-protein phosphatase non-receptor type 6 [KO:K05697] [EC:3.1.3.48]
101435481  TNFSF10; tumor necrosis factor ligand superfamily member 10 isoform X1 [KO:K04721]
101435652  PAK1; serine/threonine-protein kinase PAK 1 [KO:K04409] [EC:2.7.11.1]
101435742  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
101435854  PPP3CB; serine/threonine-protein phosphatase 2B catalytic subunit beta isoform isoform X1 [KO:K04348] [EC:3.1.3.16]
101436037  [KO:K06464]
101436366  [KO:K07987]
101436645  [KO:K06541]
101436775  [KO:K07987]
101438083  TNFRSF10B; tumor necrosis factor receptor superfamily member 10B isoform X1 [KO:K04722]
101438211  SYK; tyrosine-protein kinase SYK isoform X2 [KO:K05855] [EC:2.7.10.2]
101438260  SHC1; SHC-transforming protein 1 [KO:K06279]
101438266  BID; BH3-interacting domain death agonist isoform X1 [KO:K04726]
101438360  [KO:K06541]
101438406  [KO:K07987]
101440141  PTK2B; protein-tyrosine kinase 2-beta [KO:K05871] [EC:2.7.10.2]
101440970  [KO:K06268]
101441936  CASP3; caspase-3 isoform X1 [KO:K02187] [EC:3.4.22.56]
101443248  [KO:K07860]
101443761  PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
101444276  PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:2.7.1.153]
101444441  SH2D1B; SH2 domain-containing protein 1B [KO:K07989]
101445129  LCK; tyrosine-protein kinase Lck [KO:K05856] [EC:2.7.10.2]
101446965  VAV2; guanine nucleotide exchange factor VAV2 isoform X1 [KO:K05730]
101447167  NCR1; natural cytotoxicity triggering receptor 1 isoform X1 [KO:K06741]
101447321  SHC2; SHC-transforming protein 2 [KO:K17447]
101447351  PRKCG; protein kinase C gamma type isoform X1 [KO:K19663] [EC:2.7.11.13]
101447838  PRKCA; protein kinase C alpha type isoform X1 [KO:K02677] [EC:2.7.11.13]
101447879  [KO:K05414]
105744140  FCER1G; high affinity immunoglobulin epsilon receptor subunit gamma [KO:K07983]
Compound
C00076  Calcium cation
C00165  Diacylglycerol
C01245  D-myo-Inositol 1,4,5-trisphosphate
C05981  Phosphatidylinositol-3,4,5-trisphosphate
Reference
  Authors
Chiesa S, Tomasello E, Vivier E, Vely F.
  Title
Coordination of activating and inhibitory signals in natural killer cells.
  Journal
Mol Immunol 42:477-84 (2005)
DOI:10.1016/j.molimm.2004.07.030
Reference
  Authors
Maghazachi AA.
  Title
Insights into seven and single transmembrane-spanning domain receptors and their signaling pathways in human natural killer cells.
  Journal
Pharmacol Rev 57:339-57 (2005)
DOI:10.1124/pr.57.3.5
Reference
  Authors
Vivier E, Nunes JA, Vely F.
  Title
Natural killer cell signaling pathways.
  Journal
Science 306:1517-9 (2004)
DOI:10.1126/science.1103478
Reference
  Authors
Colucci F, Di Santo JP, Leibson PJ.
  Title
Natural killer cell activation in mice and men: different triggers for similar weapons?
  Journal
Nat Immunol 3:807-13 (2002)
DOI:10.1038/ni0902-807
Reference
  Authors
Perussia B.
  Title
Signaling for cytotoxicity.
  Journal
Nat Immunol 1:372-4 (2000)
DOI:10.1038/80808
Reference
  Authors
Smyth MJ, Cretney E, Kelly JM, Westwood JA, Street SE, Yagita H, Takeda K, van Dommelen SL, Degli-Esposti MA, Hayakawa Y.
  Title
Activation of NK cell cytotoxicity.
  Journal
Mol Immunol 42:501-10 (2005)
DOI:10.1016/j.molimm.2004.07.034
Reference
  Authors
Djeu JY, Jiang K, Wei S.
  Title
A view to a kill: signals triggering cytotoxicity.
  Journal
Clin Cancer Res 8:636-40 (2002)
Reference
  Authors
Smyth MJ, Takeda K, Hayakawa Y, Peschon JJ, van den Brink MR, Yagita H.
  Title
Nature's TRAIL--on a path to cancer immunotherapy.
  Journal
Immunity 18:1-6 (2003)
DOI:10.1016/S1074-7613(02)00502-2
Reference
  Authors
Colonna M.
  Title
Fine-tuning NK cell responses: it's a family affair.
  Journal
Nat Immunol 6:961-2 (2005)
DOI:10.1038/ni1005-961
Reference
PMID:8942070
  Authors
Bonnema JD, Leibson PJ.
  Title
Signal transduction during NK cell activation.
  Journal
Chem Immunol 64:28-43 (1996)
Reference
  Authors
Tassi I, Presti R, Kim S, Yokoyama WM, Gilfillan S, Colonna M.
  Title
Phospholipase C-gamma 2 is a critical signaling mediator for murine NK cell activating receptors.
  Journal
J Immunol 175:749-54 (2005)
DOI:10.4049/jimmunol.175.2.749
Reference
PMID:9143705
  Authors
Rao A, Luo C, Hogan PG.
  Title
Transcription factors of the NFAT family: regulation and function.
  Journal
Annu Rev Immunol 15:707-47 (1997)
DOI:10.1146/annurev.immunol.15.1.707
Reference
  Authors
Wu J, Lanier LL.
  Title
Natural killer cells and cancer.
  Journal
Adv Cancer Res 90:127-56 (2003)
DOI:10.1016/S0065-230X(03)90004-2
Reference
  Authors
Cerwenka A, Lanier LL.
  Title
Natural killer cells, viruses and cancer.
  Journal
Nat Rev Immunol 1:41-9 (2001)
DOI:10.1038/35095564
Reference
  Authors
Blott EJ, Griffiths GM.
  Title
Secretory lysosomes.
  Journal
Nat Rev Mol Cell Biol 3:122-31 (2002)
DOI:10.1038/nrm732
Reference
  Authors
Lieberman J.
  Title
The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal.
  Journal
Nat Rev Immunol 3:361-70 (2003)
DOI:10.1038/nri1083
Reference
  Authors
Lord SJ, Rajotte RV, Korbutt GS, Bleackley RC.
  Title
Granzyme B: a natural born killer.
  Journal
Immunol Rev 193:31-8 (2003)
DOI:10.1034/j.1600-065X.2003.00044.x
Reference
  Authors
Liu D, Xu L, Yang F, Li D, Gong F, Xu T.
  Title
Rapid biogenesis and sensitization of secretory lysosomes in NK cells mediated by target-cell recognition.
  Journal
Proc Natl Acad Sci U S A 102:123-7 (2005)
DOI:10.1073/pnas.0405737102
Reference
PMID:9862693
  Authors
Trotta R, Puorro KA, Paroli M, Azzoni L, Abebe B, Eisenlohr LC, Perussia B.
  Title
Dependence of both spontaneous and antibody-dependent, granule exocytosis-mediated NK cell cytotoxicity on extracellular signal-regulated kinases.
  Journal
J Immunol 161:6648-56 (1998)
Reference
  Authors
Jevremovic D, Billadeau DD, Schoon RA, Dick CJ, Leibson PJ.
  Title
Regulation of NK cell-mediated cytotoxicity by the adaptor protein 3BP2.
  Journal
J Immunol 166:7219-28 (2001)
DOI:10.4049/jimmunol.166.12.7219
Related
pathway
dnm04010  MAPK signaling pathway
dnm04020  Calcium signaling pathway
dnm04060  Cytokine-cytokine receptor interaction
dnm04210  Apoptosis
dnm04630  JAK-STAT signaling pathway
KO pathway
ko04650   

DBGET integrated database retrieval system